Clinical Trial

Pain Control Following Third Molar Surgery

Unknown Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 23, 2024 (before its estimated August 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
In this study, the investigators recruited patients undergoing surgical removal of impacted third molar teeth. Participants will be randomly divided into two groups Group 1: The patient will receive 400mg of ibuprofen plus 1000mg of Paracetamol simultaneously every 8 hours for two days. Group 2- The patient will receive 400mg ibuprofen and 1000mg Paracetamol at 4 hours in intervals for two days. With a total of 3 doses of ibuprofen and 3 doses of paracetamol per day Then, pain control will be assessed using various primary and secondary outcome scales.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06514222
Lead Sponsor University of Sharjah
Conditions Post Operative Pain, Impacted Third Molar Tooth
Enrollment 56 participants
Start Date 2024-07-01
Primary Completion 2024-08-31 (estimated)
Study Completion 2024-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-23